New registry aims to unlock secrets of rare diseases

NCT ID NCT06573723

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is creating a large database to collect information on people with rare diseases like amyloidosis, sarcoidosis, and Gaucher disease. Researchers will track patients' health over time, including their symptoms, treatments, and outcomes. The goal is to improve diagnosis and care for these often-misunderstood conditions.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this registry could help doctors spot rare diseases earlier and better understand how they progress and respond to treatments.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test new therapies. Results depend on data quality and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Italiano de Buenos Aires

    RECRUITING

    Buenos Aires, Buenos Aires, C1199ABB, Argentina

More trials for these conditions

Other studies related to the condition(s) this trial covers.